VIR – vir biotechnology, inc. (US:NASDAQ)
Stock Stats
News
Vir Biotechnology (NASDAQ:VIR) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Vir Biotechnology (NASDAQ:VIR) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Vir Biotechnology to Participate in the 8th Annual Evercore Healthcare Conference
Global Leaders Driving The Future Of Healthcare At The 2025 Forbes Healthcare Summit [Forbes]
Vir Biotechnology Announces AASLD The Liver Meeting® Presentation & New England Journal of Medicine Publication of Phase 2 Data Demonstrating Tobevibart & Elebsiran Combination Deliver High Rates of Undetectable HDV RNA with Favorable Safety Profile [Yaho
Form 4 Vir Biotechnology, Inc. For: Dec 01 Filed by: SVF Endurance (Cayman) Ltd
Form 4 Vir Biotechnology, Inc. For: Dec 01 Filed by: SATO VICKI L
Form 4 Vir Biotechnology, Inc. For: Nov 26 Filed by: SVF Endurance (Cayman) Ltd
Form 4 Vir Biotechnology, Inc. For: Nov 24 Filed by: SVF Endurance (Cayman) Ltd
Form 144 Vir Biotechnology, Inc. Filed by: SVF Endurance (Cayman) Ltd
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.